Citadel Advisors - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$21,708
-31.6%
10,800
-31.0%
0.00%
Q2 2023$31,751
-61.3%
15,641
-62.0%
0.00%
Q1 2023$82,010
+63.3%
41,211
+93.7%
0.00%
Q4 2022$50,223
-48.2%
21,281
-54.5%
0.00%
Q3 2022$97,000
-58.7%
46,810
-50.3%
0.00%
Q2 2022$235,000
-1.3%
94,133
-8.6%
0.00%
Q1 2022$238,000
+23.3%
102,937
+15.1%
0.00%
Q4 2021$193,000
-14.2%
89,467
+18.0%
0.00%
Q3 2021$225,000
-16.4%
75,807
-1.1%
0.00%
Q2 2021$269,000
+2.7%
76,686
+6.8%
0.00%
Q1 2021$262,000
+482.2%
71,798
+605.8%
0.00%
Q3 2020$45,00010,1720.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 706,930$1,406,7911.22%
Newtyn Management, LLC 519,765$1,034,3320.20%
Murchinson Ltd. 52,800$100,6800.01%
Marquette Asset Management, LLC 17,318$34,4630.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$93,4270.00%
Tekla Capital Management LLC 32,461$64,5970.00%
OSAIC HOLDINGS, INC. 57$1130.00%
DIMENSIONAL FUND ADVISORS LP 42,502$84,5790.00%
Parallel Advisors, LLC 244$4860.00%
BANK OF AMERICA CORP /DE/ 31$620.00%
View complete list of ARCA BIOPHARMA INC shareholders